Allergy Drug Recalled; Trump's Generic Drug Tax; Nurses Gambling to Fund Degrees
Rising Pharma has issued a nationwide recall for cetirizine antihistamine bottles. The recall stems from potential cross-contamination with ranitidine during the manufacturing process. Consumers should check their medicine cabinets and follow FDA guidance if they possess the affected products.
Public health challenges are mounting across several fronts. The United States just reached a 35-year high for measles with 2,295 confirmed cases this year. Meanwhile, New York City officials reported a fifth death tied to an ongoing Legionnaires' disease outbreak. Internationally, Ebola continues to spread in Congo, with the death toll now at 999 cases.
Economic policy changes will soon shift the pharmaceutical landscape. President Donald Trump announced a 100% tariff on imported generic drugs beginning in August 2028, with the levy increasing to 200% the following year. This trade policy represents a significant change in how foreign-made medications reach the domestic market.
Other industry updates include a legal dispute between Novo Nordisk and Eli Lilly regarding advertising claims for obesity and diabetes medications. Additionally, a recent survey indicates that nursing students are increasingly using betting platforms to fund their education expenses. These developments highlight a period of instability across both medical regulation and student financial support systems.